Overview

Nepal Undifferentiated Febrile Illness Trial

Status:
Unknown status
Trial end date:
2020-08-04
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether azithromycin or cotrimoxazole is the best empirical treatment for undifferentiated febrile illness in Nepal
Phase:
Phase 3
Details
Lead Sponsor:
Oxford University Clinical Research Unit, Vietnam
Collaborators:
University of Oxford
Wellcome Trust
Treatments:
Azithromycin
Trimethoprim, Sulfamethoxazole Drug Combination